Fei Zheng1, Ping Yin1, Yujian Wang1, Wenhan Hao1, Qi Hao1, Xuzhu Chen2, and Nan Hong1
1Peking University people' hospital, Beijing, China, 2Beijing Tiantan Hospital, Beijing, China
Synopsis
Keywords: Neuroinflammation, Brain, Encephalitis · Gliomas · Magnetic resonance imaging
Motivation: Encephalitis and glioma can appear very similar in atypical cases. However, their treatment protocols differ significantly. As such, distinguishing between these two diseases is crucial.
Goal(s): Our objective is to assess and compare the performance of various machine learning (ML) techniques in discriminating between encephalitis and glioma in atypical cases.
Approach: We compare the performance of the classical machine learning (CML) model and the deep learning (DL) model, and assess the effectiveness of utilizing radiomics features extracted from both CML and DL in distinguishing encephalitis from glioma in atypical cases.
Results: ML models can distinguish between encephalitis and glioma in atypical cases.
Impact: Surgery is commonly considered as the initial treatment for glioma, while non-operative therapy is the primary approach for managing encephalitis. Precise identification of glioma and encephalitis facilitates physicians in avoiding misdiagnosis and delays in treatment.
Introduction
In atypical cases where encephalitis and glioma
exhibit very similar manifestations, the laboratory tests are atypical, and the
clinical symptoms and signs of these conditions often coincide [1-6]. This diagnostic
dilemma can result in unintentional surgery or delayed treatment [7]. Therefore, it is paramount to explore
alternative noninvasive diagnostic tools to guide appropriate treatment.
Presently, machine learning (ML) is extensively
employed in the field of neurological diseases to enhance clinical
decision-making. Several studies have demonstrated that ML can distinguish the various pathological subtypes of gliomas [8] and assess the status of molecular and genetic markers associated with the
brain tumor [9]. It has been employed to distinguish between
glioblastoma and tumefactive demyelinating lesions [10]. These studies suggest that ML proves to be a potent analytical tool in
evaluating radiological data related to glioma and encephalitis.
The objective of this study was to compare
the performance of the classical machine learning (CML) model and the deep learning (DL) model, and to assess the effectiveness of utilizing radiomics features extracted from
both CML and DL in distinguishing encephalitis from glioma in atypical cases.
Methods
In this study, 116 patients (mean age ± standard
deviation, 42.3 ± 17.2 years old; 63 men and 53 women) pathologically
confirmed as gliomas and clinically diagnosed with encephalitis in our
medical institute between January 1, 2019 and March 31, 2023 were recruited.
In the current study, we aimed to establish 3 ML
models: (1) Task 1 consisted of establishing 3 CML models (Logistic Regression,
LR; Support Vector Machine, SVM; and Multi-Layer Perceptron, MLP) using the
FLAIR sequence; (2) Task 2 involved constructing 3 DL models (DenseNet 121,
ResNet 50, and ResNet 18) based on FLAIR sequence; and (3) Task 3 focused on
building 2 fusion models, which are feature fusion model and predictive score
fusion model. The feature fusion model was based on selecting FLAIR-based CML
features and DL features. The features were then combined to create a deep
learning radiomics (DLR) model. The predictive score fusion
model, a deep learning radiomics nomogram (DLRN), was constructed by combining CML
and DL scores using multivariate LR. An online web calculator embedding a dynamic nomogram with binary logistic regression model
was also developed.
Results
In the validation set, the best DL model (ResNet50) consistently outperformed the best CML model(LR), achieving an AUC of 0.839, accuracy of 0.875,
sensitivity of 0.929, specificity of 0.800, PPV of 0.867, and NPV of 0.889. The DLR model
exhibited the highest performance. The DLR model, which is considered the
optimal model, demonstrated the highest AUC values on both the training and
validation cohorts, reaching 0.999 and 0.879 respectively. In addition, a deep learning radiomics nomogram (DLRN) and a web
calculator were designed as a tool to aid clinical decision-making.Conclusion
In conclusion, our findings demonstrate
the potential utility of ML based on FLAIR for distinguishing atypical cases of
encephalitis and glioma which suggests its potential application in assisting
clinical decision-making is noteworthy.Acknowledgements
NoneReferences
[1] Lu J, Zhang JH, Miao AL, et
al. Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report. BMC Neurol. 2019;19(1):210.
[2] Nagata
R, Ikeda K, Nakamura Y, et al. A case of gliomatosis cerebri mimicking limbic encephalitis: malignant
transformation to glioblastoma. Intern Med. 2010;49(13):1307-1310.
[3] Panagopoulos D,
Themistocleous M, Apostolopoulou K, Sfakianos G. Herpes Simplex Encephalitis
Initially Erroneously Diagnosed as Glioma of the Cerebellum: Case Report and
Literature Review. World Neurosurg. 2019;129:421-427.
[4] Piper K, Foster H, Gabel B,
Nabors B, Cobbs C. Glioblastoma Mimicking Viral Encephalitis Responds to
Acyclovir: A Case Series and Literature Review. Front Oncol. 2019;9:8.
[5] Talathi S, Gupta N,
Reddivalla N, Prokhorov S, Gold M. Anaplastic astrocytoma mimicking herpes
simplex encephalitis in 13-year old girl. Eur J Paediatr Neurol.
2015;19(6):722-725.
[6] Vogrig A, Joubert B, Ducray
F, et al. Glioblastoma as differential diagnosis of autoimmune encephalitis. J
Neurol. 2018;265(3):669-677.
[7] Goodfellow JA, Mackay GA. Autoimmune encephalitis. J R Coll Physicians
Edinb. 2019;49(4):287-294.
[8] Qian Z, Zhang L, Hu J, et al.
Corrigendum: Machine Learning-Based Analysis of Magnetic Resonance Radiomics
for the Classification of Gliosarcoma and Glioblastoma. Front Oncol. 2021;11:774369.
[9] Zheng F,
Chen B, Zhang L, et al. Radiogenomic
Analysis of Vascular Endothelial Growth Factor in Patients With Glioblastoma. J
Comput Assist Tomogr. 2023.
[10] Zhang Y, Liang K, He J, et al.
Deep Learning With Data Enhancement for the Differentiation of Solitary and
Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion.
Front Oncol. 2021;11:665891.